X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (819) 819
Publication (76) 76
Patent (33) 33
Book Chapter (4) 4
Conference Proceeding (3) 3
Book / eBook (2) 2
Dissertation (2) 2
Book Review (1) 1
Magazine Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (320) 320
hematology (229) 229
index medicus (211) 211
male (176) 176
female (171) 171
oncology (168) 168
middle aged (166) 166
adult (158) 158
aged (150) 150
chronic myelogenous leukemia (135) 135
imatinib mesylate (134) 134
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (126) 126
benzamides (104) 104
chronic myeloid leukemia (100) 100
pyrimidines - therapeutic use (99) 99
antineoplastic agents - therapeutic use (86) 86
treatment outcome (86) 86
leukemia (83) 83
leukemia, myelogenous, chronic, bcr-abl positive - genetics (83) 83
chronic myeloid-leukemia (82) 82
piperazines - therapeutic use (81) 81
fusion proteins, bcr-abl - genetics (78) 78
imatinib (78) 78
aged, 80 and over (77) 77
bcr-abl (69) 69
cancer (62) 62
dasatinib (61) 61
hemic and lymphatic diseases (61) 61
protein kinase inhibitors - therapeutic use (61) 61
therapy (60) 60
adolescent (58) 58
medicine & public health (57) 57
care and treatment (54) 54
prognosis (52) 52
pyrimidines - administration & dosage (48) 48
young adult (47) 47
mutation (44) 44
analysis (42) 42
research (42) 42
cml (41) 41
follow-up studies (40) 40
interferon-alpha (39) 39
tyrosine kinase inhibitors (39) 39
abridged index medicus (38) 38
pyrimidines - adverse effects (38) 38
cancer research (37) 37
follow-up (35) 35
leukemia, myelogenous, chronic, bcr-abl positive - pathology (35) 35
piperazines - administration & dosage (35) 35
chronic-phase (34) 34
antineoplastic combined chemotherapy protocols - therapeutic use (33) 33
internal medicine (33) 33
leukemia, myelogenous, chronic, bcr-abl positive - diagnosis (33) 33
nilotinib (33) 33
acute lymphoblastic-leukemia (31) 31
blast crisis (31) 31
disease-free survival (31) 31
drug resistance, neoplasm (31) 31
chemotherapy (30) 30
leukemia, myelogenous, chronic, bcr-abl positive - mortality (30) 30
leukemia, myelogenous, chronic, bcr-abl positive - therapy (30) 30
protein kinase inhibitors - administration & dosage (30) 30
protein-tyrosine kinases - antagonists & inhibitors (30) 30
antineoplastic agents (29) 29
antineoplastic agents - administration & dosage (29) 29
chemistry (29) 29
drug therapy (29) 29
fusion proteins, bcr-abl - metabolism (29) 29
hematology, oncology and palliative medicine (29) 29
microbiology (29) 29
survival (29) 29
antineoplastic agents - adverse effects (28) 28
beer (28) 28
biochemistry (28) 28
compositions or test papers therefor (28) 28
condition-responsive control in microbiological orenzymological processes (28) 28
enzymology (28) 28
measuring or testing processes involving enzymes, nucleicacids or microorganisms (28) 28
metallurgy (28) 28
mutation or genetic engineering (28) 28
processes of preparing such compositions (28) 28
pyrimidines - pharmacology (28) 28
spirits (28) 28
vinegar (28) 28
wine (28) 28
philadelphia-chromosome (27) 27
thiazoles - therapeutic use (27) 27
compositions thereof (26) 26
culture media (26) 26
drug resistance, neoplasm - genetics (26) 26
microorganisms or enzymes (26) 26
piperazines - pharmacology (26) 26
propagating, preserving or maintaining microorganisms (26) 26
survival analysis (26) 26
survival rate (26) 26
cells (25) 25
organic chemistry (25) 25
piperazines - adverse effects (25) 25
remission induction (25) 25
diagnosis (24) 24
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Mathew, Nimitha R and Baumgartner, Francis and Braun, Lukas and O'Sullivan, David and Thomas, Simone and Waterhouse, Miguel and Müller, Tony A and Hanke, Kathrin and Taromi, Sanaz and Apostolova, Petya and Illert, Anna L and Melchinger, Wolfgang and Duquesne, Sandra and Schmitt-Graeff, Annette and Osswald, Lena and Yan, Kai-Li and Weber, Arnim and Tugues, Sonia and Spath, Sabine and Pfeifer, Dietmar and Follo, Marie and Claus, Rainer and Lübbert, Michael and Rummelt, Christoph and Bertz, Hartmut and Wäsch, Ralph and Haag, Johanna and Schmidts, Andrea and Schultheiss, Michael and Bettinger, Dominik and Thimme, Robert and Ullrich, Evelyn and Tanriver, Yakup and Vuong, Giang Lam and Arnold, Renate and Hemmati, Philipp and Wolf, Dominik and Ditschkowski, Markus and Jilg, Cordula and Wilhelm, Konrad and Leiber, Christian and Gerull, Sabine and Halter, Jörg and Lengerke, Claudia and Pabst, Thomas and Schroeder, Thomas and Kobbe, Guido and Rösler, Wolf and Doostkam, Soroush and Meckel, Stephan and Stabla, Kathleen and Metzelder, Stephan K and Halbach, Sebastian and Brummer, Tilman and Hu, Zehan and Dengjel, Joern and Hackanson, Björn and Schmid, Christoph and Holtick, Udo and Scheid, Christof and Spyridonidis, Alexandros and Stölzel, Friedrich and Ordemann, Rainer and Müller, Lutz P and Sicre-De-Fontbrune, Flore and Ihorst, Gabriele and Kuball, Jürgen and Ehlert, Jan E and Feger, Daniel and Wagner, Eva-Maria and Cahn, Jean-Yves and Schnell, Jacqueline and Kuchenbauer, Florian and Bunjes, Donald and Chakraverty, Ronjon and Richardson, Simon and Gill, Saar and Kröger, Nicolaus and Ayuk, Francis and Vago, Luca and Ciceri, Fabio and Müller, Antonia M and Kondo, Takeshi and Teshima, Takanori and Klaeger, Susan and Kuster, Bernhard and Kim, Dennis H and Weisdorf, Daniel and Van Der Velden, Walter and Dörfel, Daniela and Bethge, Wolfgang and Hilgendorf, Inken and Hochhaus, Andreas and Andrieux, Geoffroy and Börries, Melanie and Busch, Hauke and Magenau, John and Reddy, Pavan and Labopin, Myriam and Antin, Joseph H and ...
Nature Medicine, ISSN 1078-8956, 03/2018, Volume 24, Issue 3, pp. 282 - 291
Journal Article
Journal Article
by Mathew, Nimitha R and Baumgartner, Francis and Braun, Lukas and O'Sullivan, David and Thomas, Simone and Waterhouse, Miguel and Müller, Tony A and Hanke, Kathrin and Taromi, Sanaz and Apostolova, Petya and Illert, Anna L and Melchinger, Wolfgang and Duquesne, Sandra and Schmitt-Graeff, Annette and Osswald, Lena and Yan, Kai-Li and Weber, Arnim and Tugues, Sonia and Spath, Sabine and Pfeifer, Dietmar and Follo, Marie and Claus, Rainer and Lübbert, Michael and Rummelt, Christoph and Bertz, Hartmut and Wäsch, Ralph and Haag, Johanna and Schmidts, Andrea and Schultheiss, Michael and Bettinger, Dominik and Thimme, Robert and Ullrich, Evelyn and Tanriver, Yakup and Vuong, Giang Lam and Arnold, Renate and Hemmati, Philipp and Wolf, Dominik and Ditschkowski, Markus and Jilg, Cordula and Wilhelm, Konrad and Leiber, Christian and Gerull, Sabine and Halter, Jörg and Lengerke, Claudia and Pabst, Thomas and Schroeder, Thomas and Kobbe, Guido and Rösler, Wolf and Doostkam, Soroush and Meckel, Stephan and Stabla, Kathleen and Metzelder, Stephan K and Halbach, Sebastian and Brummer, Tilman and Hu, Zehan and Dengjel, Joern and Hackanson, Björn and Schmid, Christoph and Holtick, Udo and Scheid, Christof and Spyridonidis, Alexandros and Stölzel, Friedrich and Ordemann, Rainer and Müller, Lutz P and Sicre-de-Fontbrune, Flore and Ihorst, Gabriele and Kuball, Jürgen and Ehlert, Jan E and Feger, Daniel and Wagner, Eva-Maria and Cahn, Jean-Yves and Schnell, Jacqueline and Kuchenbauer, Florian and Bunjes, Donald and Chakraverty, Ronjon and Richardson, Simon and Gill, Saar and Kröger, Nicolaus and Ayuk, Francis and Vago, Luca and Ciceri, Fabio and Müller, Antonia M and Kondo, Takeshi and Teshima, Takanori and Klaeger, Susan and Kuster, Bernhard and Kim, Dennis Dong Hwan and Weisdorf, Daniel and van der Velden, Walter and Dörfel, Daniela and Bethge, Wolfgang and Hilgendorf, Inken and Hochhaus, Andreas and Andrieux, Geoffroy and Börries, Melanie and Busch, Hauke and Magenau, John and Reddy, Pavan and Labopin, Myriam and Antin, Joseph H and ...
Nature medicine, ISSN 1078-8956, 04/2018, Volume 24, Issue 4, pp. 526 - 526
This corrects the article DOI: 10.1038/nm.4484. 
Interleukin 15 | Leukemia | Rodents
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2014, Volume 32, Issue 5, pp. 415 - 423
Purpose Deep molecular response (MR4.5) defines a subgroup of patients with chronic myeloid leukemia (CML) who may stay in unmaintained remission after... 
MESYLATE | INTERFERON-ALPHA | THERAPY | CHRONIC-PHASE | ONCOLOGY | RECOMMENDATIONS | CLINICAL-TRIALS | 800 MG | END-POINTS | EUROPEAN-LEUKEMIANET | CHRONIC MYELOID-LEUKEMIA | Piperazines - administration & dosage | Humans | Middle Aged | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Male | Protein Kinase Inhibitors - adverse effects | Molecular Targeted Therapy | Young Adult | Benzamides - administration & dosage | Time Factors | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology | Aged, 80 and over | Adult | Female | Benzamides - adverse effects | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - mortality | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - enzymology | Pyrimidines - administration & dosage | Risk Factors | Proportional Hazards Models | Treatment Outcome | Imatinib Mesylate | Piperazines - adverse effects | Remission Induction | Cytarabine - administration & dosage | Disease Progression | Interferon-alpha - administration & dosage | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Fusion Proteins, bcr-abl - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Fusion Proteins, bcr-abl - antagonists & inhibitors | Pyrimidines - adverse effects | Aged | Fusion Proteins, bcr-abl - metabolism
Journal Article
The Lancet Oncology, ISSN 1470-2045, 06/2018, Volume 19, Issue 6, pp. 747 - 757
Journal Article
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer, ISSN 0080-0015, 2014, Volume 201, pp. 27 - 65
Journal Article
Blood, ISSN 0006-4971, 01/2012, Volume 119, Issue 2, pp. 530 - 539
Journal Article
Blood, ISSN 0006-4971, 03/2012, Volume 119, Issue 12, pp. 2965 - 2966
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 9, pp. 841 - 851
Summary Background Nilotinib has shown greater efficacy than imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid... 
Hematology, Oncology and Palliative Medicine | CHRONIC MYELOGENOUS LEUKEMIA | HALF | THERAPY | ONCOLOGY | MOLECULAR RESPONSES | RECOMMENDATIONS | HARMONIZING CURRENT METHODOLOGY | TYROSINE KINASE INHIBITOR | DISCONTINUATION | BCR-ABL TRANSCRIPTS | Piperazines - administration & dosage | Singapore | Protein-Tyrosine Kinases - metabolism | United States | Humans | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | Protein-Tyrosine Kinases - genetics | Time Factors | Antineoplastic Agents - adverse effects | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology | Brazil | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - mortality | Philadelphia Chromosome | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - enzymology | Drug Administration Schedule | Administration, Oral | Pyrimidines - administration & dosage | Europe | Kaplan-Meier Estimate | Survival Rate | Treatment Outcome | Piperazines - therapeutic use | Imatinib Mesylate | Piperazines - adverse effects | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Fusion Proteins, bcr-abl - genetics | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Fusion Proteins, bcr-abl - antagonists & inhibitors | Pyrimidines - adverse effects | Benzamides | Australia | Fusion Proteins, bcr-abl - metabolism | Protein-Tyrosine Kinases - antagonists & inhibitors | Antimitotic agents | Antineoplastic agents | Product development
Journal Article
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program, ISSN 1520-4391, 2011, Volume 2011, Issue 1, pp. 128 - 135
Journal Article